Analysis of Barriers and Facilitators to Adapted Physical Activity for Pediatric Patients With Chronic Inflammatory Bowel Diseases (Feels-Mici)

January 26, 2026 updated by: Fondation Lenval
This study aims to identify perceived barriers and facilitators to regular physical activity among children and adolescents with inflammatory bowel disease (IBD) followed in pediatric gastroenterology. Approximately 60 participants aged 10-17 years will complete two self-administered questionnaires (CAPAS-Q for physical activity/sedentary behavior and IMPACT-III for health-related quality of life) and take part in a single semi-structured interview exploring experiences, obstacles, and levers to support sustainable physical activity. Relevant clinical data (disease characteristics, treatment and selected routine clinical parameters) will be extracted from the medical record. Participation is limited to one visit (about 45-60 minutes) during a routine hospital appointment, with no additional intervention or follow-up required.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • France
      • Nice, France, 06000
        • Recruiting
        • Fondation Lenval Hôpitaux pédiatrique Nice CHU Lenval
        • Contact:
        • Contact:
        • Principal Investigator:
          • olivier Courbette, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Aged 10 to 17 years at inclusion.

  • Diagnosed inflammatory bowel disease (Crohn's disease or ulcerative colitis) confirmed and diagnosed for at least 6 months.
  • Followed in the pediatric gastroenterology department at Hôpital Lenval (CHU de Nice).
  • Sufficient cognitive and language abilities to understand questionnaires and participate in an individual interview.

Description

Inclusion Criteria:

  • Aged 10 to 17 years at inclusion.
  • Diagnosed inflammatory bowel disease (Crohn's disease or ulcerative colitis) confirmed and diagnosed for at least 6 months.
  • Followed in the pediatric gastroenterology department at Hôpital Lenval (CHU de Nice).
  • Sufficient cognitive and language abilities to understand questionnaires and participate in an individual interview.
  • Affiliated to, or beneficiary of, a social security scheme.
  • no parental objection to participation (non-opposition).

Exclusion Criteria:

  • Younger than 10 years or older than 17 years.
  • No IBD diagnosis, or IBD diagnosed less than 6 months ago.
  • Associated chronic condition (neurological, metabolic, psychiatric, or other) likely to interfere with questionnaire completion or interview participation.
  • Major language or cognitive impairment preventing adequate understanding or interview participation.
  • Not affiliated to, or not beneficiary of, a social security scheme.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pediatric IBD participants (questionnaires + interview)
This study does not involve any therapeutic or behavioral intervention. The "intervention" corresponds to data collection during a single visit: participants complete two self-administered questionnaires (CAPAS-Q and IMPACT-III) and participate in a semi-structured interview about perceived barriers and facilitators to physical activity. No counseling, training, or treatment is provided.
Other: IMPACT-III questionnaires
Participants complete the self-administered questionnaires IMPACT-III)
Other: Data collection: CAPAS-Q
Participants complete the self-administered questionnaires CAPAS-Q.
Other: semi-structured interview
participate in a semi-structured interview about perceived barriers and facilitators to physical activity. No counseling, training, or treatment is provided.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perceived barriers and facilitators to regular physical activity
Time Frame: at the inclusion
Assessed through a single semi-structured interview. Qualitative thematic analysis will be used to identify and categorize perceived barriers and facilitators to regular physical activity in pediatric IBD.
at the inclusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity level and sedentary behavior (CAPAS-Q)
Time Frame: at the inclusion
Measured using the CAPAS-Q self-administered questionnaire to describe participants' physical activity and sedentary behavior.
at the inclusion
Health-related quality of life (IMPACT-III)
Time Frame: at the inclusion
Measured using the IMPACT-III self-administered questionnaire to assess health-related quality of life in pediatric IBD.
at the inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Fondation Lenval

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 21, 2026

Primary Completion (Estimated)

January 31, 2027

Study Completion (Estimated)

January 31, 2027

Study Registration Dates

First Submitted

January 26, 2026

First Submitted That Met QC Criteria

January 26, 2026

First Posted (Actual)

February 3, 2026

Study Record Updates

Last Update Posted (Actual)

February 3, 2026

Last Update Submitted That Met QC Criteria

January 26, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 25-HPNCL-08 Feels-MICI
  • 2025-A02019-40 (Other Identifier: id-rcb)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis)

Clinical Trials on IMPACT-III questionnaires

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe